Brief: Onesource Specialty Says Onesource-Hikma Secures Approval To Commercialise Generic Ozempic In Saudi Arabia
11/02/2026 02:52
Feb 11 (Reuters) - Onesource Specialty Pharma Ltd ONEO.NS: ONESOURCE SPECIALTY - ONESOURCE-HIKMA SECURES APPROVAL TO COMMERCIALISE GENERIC OZEMPIC IN SAUDI ARABIA Source text: ID:nBSE8SwyPY Further company coverage: ONEO.NS ((reuters.briefs@thomsonreuters.com;))
Recent news on Onesource Specialty Pharma
See all newsBrief: Onesource Specialty Pharma Not To Pursue Merger Of Facilities Of Steriscienceat With Co
Brief: Onesource Specialty Pharma March-Quarter Consol Profit 46 Million Rupees
Brief: Onesource Specialty Pharma Says Orbicular Secures Tentative U.S. FDA ANDA Approval For Generic Ozempic
Brief: Onesource Specialty Pharma Says EU-GMP Certification For Unit II Manufacturing Facility Renewed
Brief: Onesource Specialty Says Onesource-Hikma Secures Approval To Commercialise Generic Ozempic In Saudi Arabia